Glostrup, Denmark

Joergen B Lassen

This inventor holds 2 USPTO granted patents. Top assignee: A/s Ferrosan. Active years: 1984-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joergen B Lassen. Retrieved from https://idiyas.com/inventor/joergen-b-lassen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.5

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1984-1988

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Joergen B Lassen: Innovator in Obesity Treatment

Introduction

Joergen B Lassen is a notable inventor based in Glostrup, Denmark. He has made significant contributions to the field of obesity treatment, holding 2 patents that focus on innovative methods for weight control and appetite suppression.

Latest Patents

His latest patents include a method for treating obesity in both humans and non-human animals. This method involves administering an effective, non-toxic amount of paroxetine or a pharmaceutically acceptable salt thereof to obese individuals. Another significant patent is for a method that assists with appetite and weight control in obese human patients. This method entails the oral or rectal administration of femoxetine, an appetite-suppressant compound, over a period of at least eight weeks.

Career Highlights

Joergen B Lassen is associated with A/S Ferrosan, where he has been instrumental in developing treatments aimed at combating obesity. His work has the potential to improve the quality of life for many individuals struggling with weight issues.

Collaborations

He has collaborated with notable coworkers such as Birte K Skrumsager and Joergen A Christensen, contributing to a dynamic research environment focused on innovative health solutions.

Conclusion

Joergen B Lassen's contributions to obesity treatment through his patents reflect his commitment to advancing medical science. His innovative approaches may pave the way for more effective treatments in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…